Thrive Phenotype B is defined by adiposity-driven inflammation load; when inflammation is being driven by visceral fat, insulin resistance, glycemic volatility, and ectopic fat, losing a meaningful amount of weight can reduce inflammatory markers as part of overall metabolic improvement, so for someone whose inflammation story is heavily adiposity-driven, GLP-1 therapy can reduce inflammatory load in a way that feels like energy returning, pain decreasing, and systemic symptoms improving.

causalpending

Speaker

Dr. Amin Dadgar

Evidence Quote

“When inflammation is being driven by visceral fat, insulin resistance, glycemic volatility, and ectopic fat, losing a meaningful amount of weight can reduce inflammatory markers”

Source

Ozempic & Mounjaro: Same Shot. Opposite Results.— Dr. Amin Hedayat, MD
Created: 8/12/2026, 6:40:36 PM

Your notes

Loading notes...